ketanserin has been researched along with Cerebral Cryptococcosis in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Excerpt | Relevance | Reference |
---|---|---|
"Treatment of life-threatening cryptococcal meningitis (CM) is highly challenging due to the limited efficacy of the available antifungal drugs." | 1.72 | Discovery of Novel Sertraline Derivatives as Potent Anti- ( Ji, C; Li, J; Li, W; Liu, N; Sheng, C; Tu, J; Yang, W; Yun, Z, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Li, W | 1 |
Yun, Z | 1 |
Ji, C | 1 |
Tu, J | 1 |
Yang, W | 1 |
Li, J | 1 |
Liu, N | 1 |
Sheng, C | 1 |
1 other study available for ketanserin and Cerebral Cryptococcosis
Article | Year |
---|---|
Discovery of Novel Sertraline Derivatives as Potent Anti-
Topics: Antidepressive Agents; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Humans; Meningitis, | 2022 |